LXR suppresses MS-associated neuroinflammation via inhibition of NF-κB and NLRP3 inflammasome signaling737 and promotes remyelination and alleviates neurodegeneration,738 while NR1H3 mutations are linked to familial MS.739. The gene discussed is NFKB1; the disease is myeloid sarcoma.